{"id":"W2123476312","doi":"10.1158/1078-0432.ccr-08-1006","title":"A Phase 1 Dose-Escalation Study of Irinotecan in Combination with 17-Allylamino-17-Demethoxygeldanamycin in Patients with Solid Tumors","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":true,"ca_institutions":"Immunovaccine (Canada)","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; Memorial Sloan-Kettering Cancer Center","keywords":"Irinotecan; Medicine; Pharmacodynamics; Response Evaluation Criteria in Solid Tumors; Pharmacokinetics; Internal medicine; Hsp90 inhibitor; Pharmacology; Oncology; Cancer; Gastroenterology; Progressive disease; Chemotherapy; Heat shock protein; Hsp90; Chemistry; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001250549,0.001905522,0.002465812,0.0005942341,0.0004266001,0.0007581197,0.0009147723,0.0009635,0.001978199],"category_scores_gemma":[0.0009253192,0.000687322,0.0010026,0.0005798145,0.00103921,0.0007661497,0.0003473281,0.003150756,0.0005641588],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001231795,"about_ca_system_score_gemma":0.001563803,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006219551,"about_ca_topic_score_gemma":0.001478619,"domain_scores_codex":[0.9992894,0.0003281237,0.00002978518,0.0001462404,0.00008275554,0.0001236486],"domain_scores_gemma":[0.999377,0.00009213119,0.0001665505,0.00006815924,0.00003577222,0.0002605229],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.531866,0.1350381,0.01996079,0.0009249313,0.001859705,0.0006176055,0.0007420792,0.007955648,0.1482291,0.0002939906,0.002737429,0.1497747],"study_design_scores_gemma":[0.2484346,0.7140725,0.02044026,0.00002640013,0.0004201137,0.0004797012,0.00005971501,0.002140249,0.01153682,0.0001490732,0.002208202,0.00003226093],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973424,0.0006558366,0.0002696108,0.0001321807,0.00002896354,0.0008903099,0.0001942623,0.00004243331,0.0004440011],"genre_scores_gemma":[0.994617,0.0006584266,0.001564708,0.0002745937,0.00006718826,0.001205748,0.0008052514,0.00001802354,0.0007890779],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002465812,"threshold_uncertainty_score":0.008937299,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1217808657535722,"score_gpt":0.482684104983306,"score_spread":0.3609032392297338,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}